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Salmonella 
enterica Serovar
Enteritidis, Japan
To the Editor: Nontyphoidal sal-
monellae are the important causative
agents of foodborne diseases in Japan
and other industrialized countries.
Salmonella enterica serovar Enter-
itidis has risen to the leading cause of
infection among Salmonella spp.
since 1989 (1). Emergence of drug-
resistant S. Enteritidis has been rarely
reported while S. Typhimurium,
another serovar of major public health
concerns, has been reported to acquire
multidrug resistance such as DT104
resistance to ampicillin, chloram-
phenicol, streptomycin, sulfonamide,
and tetracycline (R-ACSSuT) (2). 
We previously reported outbreaks
caused by strains resistant to ampi-
cillin and streptomycin (resistance
type R-AS, herein); the strains’ reac-
tions against the phages used in bacte-
riophage typing did not conform to
any known reaction patterns (phage
type [PT] RDNC-a, herein, with the
following reactions: (-) for #3, 5–7,
11–13, 15, and 16 phages; (+++) for
#2 phage; opaque lysis [OL] for #4
and  9 phages; <OL for #10 phage;
and ambiguous reactions (-/+++) were
observed for #1, 8, and 14 phages)
(3). To investigate the characters of
the R-AS strains more extensively, we
surveyed isolates from outbreaks that
occurred from 1997 to 2002 for
antimicrobial drug susceptibility and
bacteriophage typing. 
S. Enteritidis strains from 899 out-
breaks that occurred from 1997 to
2002 were tested. Bacteriophage typ-
ing was done according to the Public
Health Laboratory Service (PHLS),
London, United Kingdom guidelines
(4). Antimicrobial drug susceptibility
testing was done with a disc diffusion
method on Mueller-Hinton II agar
(Becton Dickinson Microbiology
Systems, Cockeysville, MD) as previ-
ously described (5). Antimicrobial
drugs used in this study were ampi-
cillin, streptomycin, tetracycline,
kanamycin, nalidixic acid, gen-
tamycin, sulfamethoxazole-trimetho-
prim, trimethoprim, chloramphenicol,
cefotaxim, and ciprofloxacin.
Dominant phage types were PT4
(36.9%) and PT1 (26.9%). They have
been dominant among outbreak-rela-
ted strains since 1992 (1). Other types
were also identified at certain fre-
quencies. For example, RDNC-a,
PT47, PT6, PT6a, and PT21 account-
ed for 4.4%, 5.3%, 4.0%, 3.2%, and
2.0% of the phage types, respectively.
Strains sensitive to all the antimi-
crobial drugs tested were the most
predominant (55.1%), followed by
those resistant to only streptomycin
(34.8%). R-AS was the third most
predominant, accounting for 4.1%. A
correlation existed between drug
resistance and phage types in that all
the R-AS strains (n = 37) showed
RDNC-a in bacteriophage typing, and
all the RDNC-a strains (n = 40) were
resistant to at least ampicillin includ-
ing two R-A and one R-AST strains. 
Since previous studies described
the correlation between drug resist-
ance and phage types as a result of
acquisition of an R-plasmid (6), we
focused on the relationship between
RDNC-a and ampicillin resistance.
Plasmid profiles analysis of the
RDNC-a strains showed that all but
one (R-AST) had at least two kinds of
plasmids, and all but one were
approximately 50 kb and 60 kb in
size. The last could be the so-called
serovar-specific plasmid (7). Southern
blot analysis by using the ampicillin
resistance gene of pBluescript KS (+)
(Stratagene, La Jolla, CA) as a probe
indicated that a resistance gene was
carried on the 50-kb plasmid.
Furthermore, when Escherichia coli
DH10B cells (Invitrogen Corporation,
Carlsbad, CA) were transformed with
plasmids isolated from an RDNC-a R-
AS strain and plated onto Luria broth
plates containing 100 mg/L of ampi-
cillin, the 50-kb, but not 60-kb, plas-
mid could be isolated from the ampi-
cillin-resistant transformants. And the
50-kb plasmid from the transformants
was hybridized to the probe for ampi-
cillin resistance described above.
Thus, the 50-kb plasmid of RDNC-a
R-A or -AS strains was suggested to
be an R-plasmid responsible for ampi-
cillin resistance.
A representative 50-kb plasmid
(p981123) was prepared from the
DH10B transformant cells described
earlier for further characterization.
Southern blot analysis suggested that
a 6-kb EcoRI fragment contained the
resistance determinant. Sequences for
the fragment were analyzed done by
using ABI PRISM 310 sequencer and
BigDye Terminator Cycle Sequencing
Ready Reaction Kit (Applied
Biosystems, Foster City, CA). The
resulting sequence showed high simi-
larities to Pseudomonas aeruginosa
Tn801 (accession no. AF080442; 98%
identical) and E. coli Tn3 (accession
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no. ISTN3X; 96% identical), com-
prising one of Tn3-like inverted
repeats and putative coding regions
for transposase, resolvase (also called
repressor), and ampicillin resistance.
The resistance gene encodes a TEM-1
type β-lactamase. (The sequence has
been registered to DDBJ/GenBank/
EMBLwith accession no. AB103092.) 
Conjugative transferability of
p981123 between S. Enteritidis strains
was examined by using the parental S.
Enteritidis RDNC-a R-AS strain as a
donor, and three independent S.
Enteritidis strains (PT1; PT4; and
PT21) resistant to nalidixic acid (R-
N) as recipients. p981123 was trans-
ferable between S. Enteritidis strains
at frequencies of 10-5 to 10-4, and the
resulting R-AN transconjugant
showed the same lytic pattern of the
typing phages as RDNC-a. Thus,
transfer of p981123 could convert the
phage types at least from PT1, PT4,
and PT21 to RDNC-a. Pulsed-field
gel electrophoresis (PFGE) was done
by using XbaI or BlnI as well, and
RDNC-a strains showed a variety of
PFGE profiles. These results suggest
emergence and prevalence of the 50-
kb R-plasmid converting phage types
to RDNC-a in S. Enteritidis in Japan.
Previous studies reported correla-
tion between R-plasmids and phage
types of S. Enteritidis, where, for
example, a 34-MDa R-plasmid of
incompatibility group N (IncN) (8)
and a 36-MDa R-plasmid of IncX
(pDEP57) (6) were described. Both
kinds of plasmids encoded ampicillin
resistance as well as that in this study,
but both were identified in PT6a iso-
lates. Preliminary sequence data of
the region of p981123 essential for
replication indicated a gene coding
for a protein similar to protein p1 of
R6K (IncX) plasmid (9), which sug-
gests that p981123 may be related to
pDEP57. However, the reactions to
the typing phages in RDNC-a strains
were different from those in PT6a.
Therefore, the R-plasmid in this study
seems to have different features from
previous ones. In addition, S.
Enteritidis PT6d resistant to ampi-
cillin was recently reported (10).
Relationship between RDNC-a in this
study and PT6d is unknown, and fur-
ther investigations will be needed.
Transfer of an R-plasmid is a com-
mon way for bacteria to acquire drug
resistance, and it often affects other
aspects such as sensitivity of bacterio-
phages, as described in this study.
Molecular based surveillance for drug
resistance in S. Enteritidis needs to
continue.
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Factors Influencing
Fluoroquinolone
Resistance 
To the Editor: Recently, Scheld
summarized factors that he consid-
ered to have an influence on the effi-
cacy of fluoroquinolones (1). In the
review, ciprofloxacin was presented
as the most active fluoroquinolone
against  Pseudomonas aeruginosa
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